Collegium Pharma (COLL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,255 | -17,917 | -16,197 | N/A | N/A |
| Depreciation Amortization | 171 | 187 | 169 | N/A | N/A |
| Accounts payable and accrued liabilities | 1,298 | 990 | -822 | N/A | N/A |
| Other Working Capital | 3,336 | -219 | -634 | N/A | N/A |
| Other Operating Activity | 883 | -988 | 954 | 0 | 0 |
| Operating Cash Flow | $-21,567 | $-17,947 | $-16,530 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -362 | -8 | -206 | N/A | N/A |
| Investing Cash Flow | $-362 | $-8 | $-206 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 12,056 | 500 | N/A | N/A |
| Debt Repayment | -1,345 | -90 | -105 | N/A | N/A |
| Common Stock Issued | 72,546 | 72 | 1 | N/A | N/A |
| Other Financing Activity | 44,791 | 0 | 11,955 | 0 | 0 |
| Financing Cash Flow | $115,992 | $12,038 | $12,351 | $N/A | $N/A |
| Beginning Cash Position | 1,634 | 7,551 | 11,936 | N/A | N/A |
| End Cash Position | 95,697 | 1,634 | 7,551 | N/A | N/A |
| Net Cash Flow | $94,063 | $-5,917 | $-4,385 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,567 | -17,947 | -16,530 | N/A | N/A |
| Capital Expenditure | -362 | -8 | -206 | N/A | N/A |
| Free Cash Flow | -21,929 | -17,955 | -16,736 | 0 | 0 |